LONDON -- Platinum remains in the news -- but the action today didn't revolve around miners of the stuff, but businesses that use it. Chief among them in an FTSE 100
That said, the precise driver wasn't clear. The company hasn't issued any recent news or results, and broker coverage hasn't thrown up any news flow, either. However, with the shares down sharply in early trading, investors seemingly saw an opportunity to grab a stake in a global business that over the past year has outperformed the FTSE 100 by 30% -- and which is still on a forecast price-to-earnings ratio of 13.
Just behind Johnson Matthey, Barclays
Finally, a broker downgrade of global pharmaceutical and consumer products business GlaxoSmithKline
Finally, what are super-investors Neil Woodford and Warren Buffett buying today? We can't tell you that, but we can tell you the names of the shares they've been buying in the recent past -- and why they've been buying them.
Are you looking to profit from this uncertain economy? "10 Steps To Making A Million In The Market" is the very latest Motley Fool guide to help Britain invest. Better. We urge you to read the report today -- it's free.
More investing ideas from Malcolm Wheatley:
Malcolm owns shares in GlaxoSmithKline but has no disclosable interest in any other share listed. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.
Disclaimer: The TD Direct Investing (www.tddirectinvesting.co.uk) list of Top Ten Buys should not be taken as a recommendation to buy or sell any particular bond or stock, and is not intended as any form of advice. Instead, it is simply an indication of the general buying trends among TD Direct Investing customers during the period stated.